sellModerate cluster of 310b5-1 plan
Xiaodong Wang sold $9.2M of ONC
director, other at BeiGene, Ltd.. 48,351 shares at an average of $190.08, traded Nov 26, 2024, filed Nov 29, 2024.
Warning score
40Value
$9.2M
48,351 shares
Holdings after
0
-119% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- +25Trade size$9.2M at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001651308-24-000158, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 26, 2024 | MOption exercise American Depositary Shares10b5-1 | +38,461 | $6.50 | $250k | 40,468 | Nov 29, 2024 |
| Nov 26, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -4,425 | $187.16 | $828k | 36,043 | Nov 29, 2024 |
| Nov 26, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -300 | $187.61 | $56k | 35,743 | Nov 29, 2024 |
| Nov 26, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -5,875 | $187.98 | $1.1M | 29,868 | Nov 29, 2024 |
| Nov 26, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -400 | $188.55 | $75k | 29,468 | Nov 29, 2024 |
| Nov 26, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -2,700 | $189.17 | $511k | 26,768 | Nov 29, 2024 |
| Nov 26, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -200 | $189.76 | $38k | 26,568 | Nov 29, 2024 |
| Nov 26, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -6,187 | $190.32 | $1.2M | 20,381 | Nov 29, 2024 |
| Nov 26, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -700 | $191.05 | $134k | 19,681 | Nov 29, 2024 |
| Nov 26, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -12,293 | $191.22 | $2.4M | 7,388 | Nov 29, 2024 |
| Nov 26, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -407 | $191.81 | $78k | 6,981 | Nov 29, 2024 |
| Nov 26, 2024 | SOpen-market sale American Depositary Shares10b5-1 | -6,981 | $191.96 | $1.3M | 0 | Nov 29, 2024 |
| Nov 26, 2024 | SOpen-market sale American Depositary Sharesindirect: See Footnote10b5-1 | -1,014 | $187.15 | $190k | 6,869 | Nov 29, 2024 |
| Nov 26, 2024 | SOpen-market sale American Depositary Sharesindirect: See Footnote10b5-1 | -1,186 | $188.08 | $223k | 5,683 | Nov 29, 2024 |
| Nov 26, 2024 | SOpen-market sale American Depositary Sharesindirect: See Footnote10b5-1 | -600 | $189.03 | $113k | 5,083 | Nov 29, 2024 |
| Nov 26, 2024 | SOpen-market sale American Depositary Sharesindirect: See Footnote10b5-1 | -1,475 | $190.31 | $281k | 3,608 | Nov 29, 2024 |
| Nov 26, 2024 | SOpen-market sale American Depositary Sharesindirect: See Footnote10b5-1 | -2,725 | $191.24 | $521k | 883 | Nov 29, 2024 |
| Nov 26, 2024 | SOpen-market sale American Depositary Sharesindirect: See Footnote10b5-1 | -883 | $191.89 | $169k | 0 | Nov 29, 2024 |
| Nov 26, 2024 | MOption exercise Share Option (Right to Buy)derivative10b5-1 | -499,993 | $0.00 | $0 | 7 | Nov 29, 2024 |
Related signals
Other insiders at BeiGene, Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 39Weak | BeiGene, Ltd. | Chan Henry Lee SVP, General Counsel | $418k 1,115 shares | -100% | |
| 33Weak | BeiGene, Ltd. | Xiaodong Wang director, other | $11M 31,028 shares | -100% | |
| 33Weak | BeiGene, Ltd. | Xiaodong Wang director, other | $13M 38,287 shares | -527% | |
| 49Moderate | BeiGene, Ltd. | Titus B. Ball Principal Accounting Officer | $47k 132 shares | -100% | |
| 83Strong | BeiGene, Ltd. | John Oyler Chief Executive Officer | $830k 3,174 shares | -100% | |
| 48Moderate | BeiGene, Ltd. | Xiaodong Wang director, other | $533k 2,007 shares | -100% | |
| 70Notable | BeiGene, Ltd. | Xiaobin Wu President and COO | $354k 1,363 shares | -100% | |
| 63Notable | BeiGene, Ltd. | Lai Wang Global Head of R&D | $267k 1,028 shares | -100% | |
| 85Strong | BeiGene, Ltd. | John Oyler Chief Executive Officer | $1.4M 5,140 shares | -100% | |
| 74Notable | BeiGene, Ltd. | Xiaobin Wu President and COO | $568k 2,173 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.